Not applicableActive Not RecruitingNCT04499534What this trial is testingBRCA1/2 Flu VaccineWho this might be right forBRCA1 MutationBRCA2 Mutation Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)Looking for participantsNCT06525636What this trial is testingA First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaWho this might be right forX-linked Hypophosphatemia Kyowa Kirin Co., Ltd. 39
Testing effectiveness (Phase 2)Study completedNCT01506609What this trial is testingStudy Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AbbVie 294
Large-scale testing (Phase 3)Ended earlyNCT01583114What this trial is testingPREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE InhibitorsWho this might be right forDilated Cardiomyopathy Institut National de la Santé Et de la Recherche Médicale, France 6
Not applicableUnknownNCT00652964What this trial is testingPHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to AdulthoodWho this might be right forCentral Alveolar Hypoventilation Syndrome National Taiwan University Hospital 20
Not applicableActive Not RecruitingNCT06733337What this trial is testingLearn About the Safety of TALZENNA in People With Prostate Cancer.Who this might be right forProstate Cancer Pfizer 1
Post-approval studies (Phase 4)UnknownNCT02404675What this trial is testingHigh Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon MutationWho this might be right forNSCLC Betta Pharmaceuticals Co., Ltd. 240
Very early researchLooking for participantsNCT07656753What this trial is testingSafety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal DystrophyWho this might be right forInherited Retinal DystrophyInherited Retinal Disease Peking Union Medical College Hospital 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Not applicableStudy completedNCT07379528What this trial is testingMesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the OutcomeWho this might be right forAcute Myeloid Leukaemia (AML) Fondazione IRCCS Policlinico San Matteo di Pavia 70
Early research (Phase 1)Active Not RecruitingNCT06461286What this trial is testingSAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)Who this might be right forOPA1 Gene MutationAutosomal Dominant Optic AtrophyHereditary Optic Atrophies+1 more PYC Therapeutics 18
Testing effectiveness (Phase 2)Ended earlyNCT04780945What this trial is testingFunctional Analysis of BRCAnessWho this might be right forOvarian Neoplasm EpithelialHomologous Recombination DeficiencyBRCA1 Mutation+1 more Leiden University Medical Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04278781What this trial is testingAG-120 in People With IDH1 Mutant ChondrosarcomaWho this might be right forChondrosarcomaChondrosarcoma, Grade 2Chondrosarcoma, Grade 3+1 more Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT03514901What this trial is testingTo Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.Who this might be right forMelanoma MetastaticBRAF V600 Mutation Intergruppo Melanoma Italiano 120
Testing effectiveness (Phase 2)Study completedNCT01116219What this trial is testingBevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).Who this might be right forLung Cancer Swiss Cancer Institute 149
Early research (Phase 1)Study completedNCT02481154What this trial is testingStudy of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 MutationWho this might be right forGlioma Institut de Recherches Internationales Servier 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230459What this trial is testingEvaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)Who this might be right forLimb Girdle Muscular DystrophyLimb-Girdle Muscular Dystrophy Type 2LGMD2I+6 more AskBio Inc 9
Testing effectiveness (Phase 2)Study completedNCT03456726What this trial is testingStudy of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene MutationWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin's Lymphoma Eisai Co., Ltd. 20
Not applicableUnknownNCT02738684What this trial is testingPredict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation TestWho this might be right forLung Adenocarcinoma Southwest Hospital, China 100
Not applicableUnknownNCT04489706What this trial is testingArsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 MutationWho this might be right forOvarian CancerEndometrial Cancer Ruijin Hospital 20